These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 9273186

  • 1. [Optimization of combined radiotherapy and chemotherapy in treatment of non-small cell lung carcinoma].
    Bretel JJ, Arriagada R, Le Chevalier T, Baldeyrou P, Grunenwald D, Le Péchoux C, Pellae-Cosset B, Ruffié P.
    Cancer Radiother; 1997; 1(2):148-53. PubMed ID: 9273186
    [Abstract] [Full Text] [Related]

  • 2. [Induction chemotherapy followed by concomitant combined radiotherapy and chemotherapy in stage III non-small cell bronchial carcinoma].
    Bouillet T, Morère JF, Mazeron JJ, Piperno-Neuman S, Boaziz C, Haddad E, Breau JL.
    Cancer Radiother; 1997; 1(2):121-31. PubMed ID: 9273182
    [Abstract] [Full Text] [Related]

  • 3. [Concomitant radiochemotherapy in inoperable non-small cell lung cancer].
    Hennequin C, Trédaniel J, Durdux C, Salemkour A, Zalcman G, Hirsch A, Housset M, Maylin C.
    Cancer Radiother; 1997; 1(2):143-7. PubMed ID: 9273185
    [Abstract] [Full Text] [Related]

  • 4. Concurrent cisplatin-vindesine and hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer.
    Le Péchoux C, Arriagada R, Le Chevalier T, Bretel JJ, Cosset BP, Ruffié P, Baldeyrou P, Grunenwald D.
    Int J Radiat Oncol Biol Phys; 1996 Jun 01; 35(3):519-25. PubMed ID: 8655375
    [Abstract] [Full Text] [Related]

  • 5. Alternating radiotherapy and chemotherapy for inoperable Stage III non-small-cell lung cancer: long-term results of two Phase II GOTHA trials. Groupe d'Oncologie Thoracique Alpine.
    Mirimanoff RO, Moro D, Bolla M, Michel G, Brambilla C, Mermillod B, Miralbell R, Alberto P.
    Int J Radiat Oncol Biol Phys; 1998 Oct 01; 42(3):487-94. PubMed ID: 9806505
    [Abstract] [Full Text] [Related]

  • 6. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer.
    Ajlouni M, Chapman R, Kim JH.
    Cancer J Sci Am; 1996 Oct 01; 2(6):314-20. PubMed ID: 9166551
    [Abstract] [Full Text] [Related]

  • 7. Mitomycin, cisplatin, and vindesine followed by radiotherapy combined with cisplatin in stage III nonsmall cell lung cancer: long-term results.
    Tejedor M, Valerdi JJ, López R, Domínguez MA, Arias F, Illarramendi JJ, Martínez E.
    Int J Radiat Oncol Biol Phys; 1995 Feb 15; 31(4):813-8. PubMed ID: 7860393
    [Abstract] [Full Text] [Related]

  • 8. Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.
    Krzakowski M, Provencio M, Utracka-Hutka B, Villa E, Codes M, Kuten A, Henke M, Lopez M, Bell D, Biti G, Merimsky O, Beorchia A, Riggi M, Caux NR, Pouget JC, Dubray B, David P.
    J Thorac Oncol; 2008 Sep 15; 3(9):994-1002. PubMed ID: 18758302
    [Abstract] [Full Text] [Related]

  • 9. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P, Herndon J, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ.
    Cancer; 1996 Jun 01; 77(11):2393-9. PubMed ID: 8635112
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Féderation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialists.
    Arriagada R, Le Chevalier T, Quoix E, Ruffie P, de Cremoux H, Douillard JY, Tarayre M, Pignon JP, Laplanche A.
    Int J Radiat Oncol Biol Phys; 1991 Jun 01; 20(6):1183-90. PubMed ID: 1646194
    [Abstract] [Full Text] [Related]

  • 16. [A combined radiochemotherapy trial for non-small cell lung cancers: initial results].
    Livartowski A, Dubray B, Dierick A, Beuzeboc P, Pouillart P, Cosset JM.
    Cancer Radiother; 1997 Jun 01; 1(2):170-3. PubMed ID: 9273190
    [Abstract] [Full Text] [Related]

  • 17. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E, Silvano G, Tibaldi C, Campoccia S, Cionini L, Conte P.
    Semin Oncol; 2000 Feb 01; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [Abstract] [Full Text] [Related]

  • 18. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
    Leyvraz S, Pasche P, Bauer J, Bernasconi S, Monnier P.
    J Clin Oncol; 1994 Sep 01; 12(9):1876-85. PubMed ID: 8083711
    [Abstract] [Full Text] [Related]

  • 19. [Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer].
    Le Chevalier T, Brisgand D, Pujol JL, Douillard JY, Monnier A, Rivière A, Chomy P, Le Groumellec A, Ruffie P, Gottfried M, Gaspard MH, Chevreau C, Alberola V, Cigolari S, Besson F, Martinez A, Besenval M, Berthaud P, Tursz T.
    Bull Cancer; 1996 May 01; 83(5):385-94. PubMed ID: 8680091
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.